Characterization of antimicrobial aerosols for administration to horses

Veterinary Therapeutics

Volumn 4, Issue 2, 2003, Pages

  McKenzie III, Harold C ^a   Barwick, Rosanne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); EQUIDAE;

EID: 79251528592     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Palmer LB, Smaldone GC, Simon SR, et al: Aerosolized antibiotics in mechanically ventilated patients: Delivery and response. Crit Care Med 26:31-39, 1998.
2. McKenzie III HC, Murray MJ: Concentrations of gentamicin in serum and bronchial lavage fluid after intravenous and aerosol administration of gentamicin to horses. Am J Vet Res 61:1185-1190, 2000.
3. Elman M, Goldstein I, Marquette CH, et al: Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 97:199-206, 2002.
4. Goldstein I, Wallet F, Robert J, et al: Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 165:171-175, 2002.
5. Geller DE, Pitlick WH, Nardella PA, et al: Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. Chest 122:219-226, 2002.
6. Lipworth BJ: Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 42:697-705, 1996.
7. Duvivier DH, Votion D, Roberts CA, et al: Inhalation therapy of equine respiratory disorders. Equine Vet Educ 11:124-130, 1999.
8. Lin HC, Cheng HF, Wang CH, et al: Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am J Resp Crit Care Med 155:2024-2029, 1997.
9. Ramsey BW, Pepe MS, Quan JM, et al: Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340:23-30, 1999.
10. Albini E, Arena E, Belluco G, et al: Activity of aerosol thiamphenicol glycinate acetylcysteinate in a mouse model of S. pyogenes pneumonia. Arzneimittelforschung 49:631-634, 1999.
11. Hamer DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 162:328-330, 2000.
12. Grassi C, De Benedetto F: Recent clinical evidence of the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate. J Chemother 14:279-284, 2002.
13. Clarke AF: Practicalities of nebulisation. Equine Vet Educ 3:45-49, 1991.
14. Beech J: Respiratory problems in foals. Vet Clin North Am Equine Pract 1:131-149, 1985.
15. Wilson WD: Foal pneumonia, in Robinson N E (ed): Current Therapy in Equine Medicine, ed 3. Philadelphia, WB Saunders, 1992, pp 466-473.
16. Lekeux P, Duvivier D: Aerosol therapy, in Lekeux, P (ed): Equine Respiratory Diseases. Ithaca, NY, International Veterinary Information Service, 2001.
17. Derksen FJ, Robinson NE: Effective use of bronchodilators in the horse. Proc World Equine Airway Symp:18, 1998.
18. Diot P, Dequin PF, Rivoire B, et al: Aerosols and anti-infectious agents. J Aerosol Med 14:55-64, 2001.
19. Phipps PR, Gonda I: Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest 97:1327-1332, 1990.
20. Martonen T, Yang Y: Deposition mechanics of pharmaceutical particles in human airways, in Hickey AJ (ed): Inhalation Aerosols: Physical and Biological Basis for Therapy. New York, Marcel Dekker, 1996, pp 57-68.
21. Gupta P, Hickey A: Contemporary approaches in aerosolized drug delivery to the lung. J Control Release 17:129-148, 1991.
22. Moren F: Aerosol dosage forms and formulations, in Moren F, Dolovich M B, Newhouse M T, Newman S P, (eds) Aerosols in Medicine: Principles, Diagnosis and Therapy. Amsterdam, Elsevier, 1993, pp 321-49.
23. Weber A, Morlin G, Cohen M, et al: Effect of nebulizer type and antibiotic concentration on device performance. Pediatr Pulmonol 23:249-260, 1997.
24. O'Callaghan C, Barry PW: The science of nebulized drug delivery. Thorax 52:S31-S44, 1997.
25. Smith SJ, Bernstein JA: Therapeutic uses of lung aerosols, in Hickey AJ (ed): Inhalation Aerosols: Physical and Biological Basis for Therapy. New York, Marcel Dekker, 1996, pp 233-269.
26. Atkins PJ, Barker NP, Mathisen D: The design and development of inhalation drug delivery systems, in Hickey AJ (ed): Pharmaceutical Inhalation Aerosol Technology. New York, Marcel Dekker, 1992, pp 155-185.
27. Hardy JG, Newman SP, Knoch M: Lung deposition from four nebulizers. Respir Med 87:461-465, 1993.
28. Votion D, Ghafir Y, Munsters K, et al: Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system. Equine Vet J 29:388-393, 1997.
29. Faurisson F, Dessanges JF, Grimfeld A, et al: Nebulizer performance: AFLM study. Respiration 62(suppl 1):13-18, 1995.
30. Duvivier DH, Votion D, Vandenput S, et al: Aerosol therapy in the equine species. Vet J 154:189-202, 1997.
31. Viel L, Tesarowski D: Radioaerosol deposition in equids. Proc AAEP 40:93-94, 1994.
32. Hess D, Fisher D, Williams P, et al: Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 110:498-505, 1996.
33. Greenspan BJ: Ultrasonic and electrohydrodynamic methods for aerosol generation, in Hickey AJ (ed): Inhalation Aerosols: Physical and Biological Basis for Therapy. New York, Marcel Dekker, 1996, pp 313-335.
34. Davis MS, Foster WM: Airflow and device effects on aerosol delivery for large animals. J Vet Pharmacol Ther 24:57-60, 2001.
35. Newman SP, Pellow PG, Clarke SW: In vitro comparison of DeVilbiss jet and ultrasonic nebulizers. Chest 92:991-994, 1987.
36. O'Riordan TB, Weinstein MD, Mao Y: Bench testing of nebulizers: A comparison of three methods. J Aerosol Med 12:59-66, 1999.
37. Sustronck B, Deprez P, Muylle E, et al: Evaluation of the nebulisation of sodium ceftiofur in the treatment of experimental Pasteurella haemolytica bronchopneumonia in calves. Res Vet Sci 59:267-271, 1995.
38. Vermeersch H, Vandenbossche G, Remon JP, et al: Pharmacokinetics of nebulized sodium ceftiofur in calves. J Vet Pharmacol Ther 19:152-154, 1996.
39. Dally MB, Kurrle S, Breslin ABX: Ventilatory effects of aerosol gentamicin. Thorax 33:54-56, 1978.
40. Chua HL, Collis GG, Le Souef PN: Bronchial response to nebulized antibiotics in children with cystic fibrosis. Eur Respir J 3:1114-1116, 1990.
41. Dickie KJ, de Groot WJ: Ventilatory effects of aerosolized kanamycin and polymyxin. Chest 63:694-697, 1973.
42. Dalby RN, Tiano SL, Hickey AJ: Medical devices for the delivery of therapeutic aerosols to the lungs, in Hickey AJ (ed): Inhalation Aerosols: Physical and Biological Basis for Therapy. New York, Marcel Dekker, 1996, pp 441-473.
43. Harrison KS, Laube BL: Bronchodilator pretreatment improves aerosol deposition uniformity in HIV-positive patients who cough while inhaling aerosolized pentamidine. Chest 106:421-426, 1994.
44. Rush BR, Hoskinson JJ, Davis EG, et al: Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. Am J Vet Res 60:764-769, 1999.